39 results on '"Ghisa, M."'
Search Results
2. OC.12.7: THIRD GENERATION OF EUS-FNB NEEDLES IN SOLID PANCREATIC LESIONS: AN ATTEMPT TO DEFINE THE RIGHT NUMBER OF NEEDLE PASSES FOR THE DIAGNOSIS
3. ERCP under conscious sedation: how far can we go?
4. Third generation of EUS-FNB needles in solid pancreatic lesions: an attempt to define the right number of needle passes for the diagnosis
5. OC.03.5 LONG-TERM EFFICACY OF PROTON PUMP INHIBITORS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
6. T.05.1 IMPEDANCE-PH FINDINGS CONFIRM THAT GRADE B ESOPHAGITIS PROVIDES CONCLUSIVE DIAGNOSIS OF GASTROESOPHAGEAL REFLUX DISEASE
7. OC.03.3 EOSINOPHILIC ESOPHAGITIS: MOST NON-RESPONDERS TO FIRST COURSE OF PPIS ACHIEVE SUSTAINED HISTOLOGICAL REMISSION FOLLOWING SEQUENTIAL TREATMENT WITH TOPICAL STEROIDS AND SECOND COURSE OF PPIS MONOTHERAPY
8. OC.08.5 EFFECTIVENESS OF EMPIRICAL SECOND-LINE H. PYLORI ERADICATION THERAPY IN ITALY: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
9. OC.08.4 ANTIBIOTIC RESISTANCE TRENDS OF ITALIAN H. PYLORI NAÏVE PATIENTS BETWEEN 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
10. AF.16 DIAGNOSTIC DELAY AND MISDIAGNOSIS IN EOSINOPHILIC ESOPHAGITIS
11. AF.24 CHARACTERISTICS OF EMPIRICAL FIRST- AND SECOND-LINE TREATMENT BETWEEN 2013-2020: ITALIAN DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
12. OC.08.2 EFFECTIVENESS OF EMPIRICAL FIRST-LINE H. PYLORI ERADICATION THERAPY IN ITALY: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
13. T04.02.8 INFLIXIMAB ORIGINATOR, INFLIXIMAB BIOSIMILAR AND ADALIMUMAB ARE EQUALLY EFFECTIVE AND SAFE IN ULCERATIVE COLITIS AND CROHN'S DISEASE – A REAL-LIFE COHORT STUDY
14. T01.02.4 FECAL EOSINOPHIL CATIONIC PROTEIN AS POTENTIAL MARKER OF DISEASE ACTIVITY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
15. T01.02.8 EOSINOPHILIC ESOPHAGITIS - VISUAL SCORE: A NOVEL PICTORIAL SELF-ADMINISTERED TOOL TO ASSESS QUALITY OF LIFE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
16. T04.01.3 REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY
17. T02.01.23 MEXILETINE INDUCED ESOPHAGEAL ULCERATION: TWO CASE REPORTS
18. T01.02.13 EOSINOPHILIC ESOPHAGITIS QUALITY OF LIFE QUESTIONNAIRE WELL CORRELATES WITH DISEASE ACTIVITY AND RESPONSE TO THERAPY IN ACTIVE EOSINOPHILIC ESOPHAGITIS PATIENTS
19. T01.02.3 LONG TERM TREATMENT WITH PROTON PUMP INHIBITORS AND TOPICAL STEROIDS IN EOSINOPHILIC ESOPHAGITIS: EFFICACY, MODALITY OF TAPERING AND FACTORS INFLUENCING OUTCOMES — A RETROSPECTIVE STUDY
20. OC.03.2 MULTIPLE RAPID SWALLOW DISCRIMINATES FUNCTIONAL FROM ANATOMICAL ESOPHAGO-GASTRIC JUNCTION OUTFLOW OBSTRUCTION
21. T04.01.21 INTESTINAL MICROBIOTA CHANGES ACCORDING TO DISEASE ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS
22. T01.01.22 HIGH RESOLUTION MANOMETRY TRADITIONAL PARAMETERS ARE NOT USEFUL TO PREDICT RESPONSE TO ENDOSCOPIC TREATMENT IN PATIENTS WITH ESOPHAGO-GASTRIC JUNCTION OUTFLOW OBSTRUCTION
23. T01.02.21 ESOPHAGEAL MOTILITY DISORDERS IN EOSINOPHILIC ESOPHAGITIS
24. T01.02.18 ACHALASIA IS A COMMON FINDING IN PATIENTS WITH EOE UNDERGOING HIGH-RESOLUTION MANOMETRY
25. P843 Intestinal microbiota changes according to disease activity in patients with ulcerative colitis
26. P668 Real-life comparison of different anti-TNF biologic therapies for ulcerative colitis treatment: A retrospective cohort study
27. Gastrointestinal: An unusual rectal finding in a patient with ulcerative colitis
28. P.07.2 DISEASE ACTIVITY INFLUENCES DISABILITY AND QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE – A CROSS-SECTIONAL STUDY
29. P.07.20 EFFECTIVENESS OF VEDOLIZUMAB IN CLINICAL REMISSION PATIENTS: UNRAVELLING THE GREY ZONE IN REAL LIFE PRACTICE
30. P.05.64 GASTRIC FUNDUS SPLENOSIS PRESENTING AS A STROMAL TUMOR AND DIAGNOSED BY ENDOSCOPIC ULTRASOUND-GUIDED SHARKCORE BIOPSY
31. P.03.7 ADHERENCE TO GUIDELINES IN THE MANAGEMENT OF ACUTE PANCREATITIS: A CLINICAL SINGLE CENTRE EXPERIENCE
32. P.02.35 INTESTINAL INVOLVEMENT IN WEGENER'S GRANULOMATOSIS MIMICKING AN INFLAMMATORY BOWEL DISEASE: A CASE REPORT
33. P.07.32 THE QUALITY OF SLEEP IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS IMPAIRED INDEPENDENTLY FROM THE DISEASE ACTIVITY STATUS – A CROSS-SECTIONAL STUDY
34. P.01.13 ADEQUACY AND DIAGNOSTIC YIELD OF A NOVEL CORE BIOPSY NEEDLE (SHARKCORE FNB NEEDLE) IN THE DIAGNOSIS OF SUBEPITHELIAL LESIONS: OUR SERIES
35. P.07.17 EFFICACY AND SAFETY OF VEDOLIZUMAB IN REAL LIFE: EXPERIENCE IN A TERTIARY REFERRAL CENTRE
36. P.03.14 UTILITY OF PANCREATIC CYSTIC FLUID GLUCOSE IN ADDICTION TO CEA IN THE DIFFERENTIATION BETWEEN NON-MUCINOUS FROM PRE-MALIGNANT MUCINOUS PANCREATIC CYSTS
37. OC.11.1 UNRESPONSIVE DYSPHAGIA TO PROTON PUMP INHIBITORS IN EOSINOPHILIC ESOPHAGITIS PATIENTS SUGGESTS TO START STEROID THERAPY WITHOUT THE NEED OF PERFORMING A SECOND UPPER ENDOSCOPY
38. OC.11.6 POOR CORRELATION BETWEEN ENDOSCOPIC FINDINGS, EOSINOPHILIC INFILTRATION AND REFLUX BURDEN IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
39. P.01.34 CLEAR CELL RENAL CARCINOMA GASTRIC METASTASIS PRESENTING WITH GASTROINTESTINAL BLEEDING: A CASE REPORT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.